[
  {
    "ts": null,
    "headline": "Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?",
    "summary": "Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=5293a16b52394c2077bd1d53d5fcb3830092fd3aeae17fd71e196b52eff6f405",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756395013,
      "headline": "Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?",
      "id": 136561882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=5293a16b52394c2077bd1d53d5fcb3830092fd3aeae17fd71e196b52eff6f405"
    }
  },
  {
    "ts": null,
    "headline": "Genedata Advances R&D Efficiency with New Unified Sample Management Solution",
    "summary": "Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of a new Sample Management module as part of their Genedata Biopharma Platform. The Genedata Biopharma Platform is the industry's leading platform for discovering and developing novel biotherapeutics, covering the full end-to-end workflow from therapeutics design and engineering to process development. It supports a broad range of therapeutic modalities out",
    "url": "https://finnhub.io/api/news?id=1f1c3fa9352e826eca966f2620509e27d8b1c10e29173a12e07fe35d46fa6861",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756384200,
      "headline": "Genedata Advances R&D Efficiency with New Unified Sample Management Solution",
      "id": 136557990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of a new Sample Management module as part of their Genedata Biopharma Platform. The Genedata Biopharma Platform is the industry's leading platform for discovering and developing novel biotherapeutics, covering the full end-to-end workflow from therapeutics design and engineering to process development. It supports a broad range of therapeutic modalities out",
      "url": "https://finnhub.io/api/news?id=1f1c3fa9352e826eca966f2620509e27d8b1c10e29173a12e07fe35d46fa6861"
    }
  },
  {
    "ts": null,
    "headline": "mRNA Biotechs - Long-Term Value Risks Abound",
    "summary": "mRNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.",
    "url": "https://finnhub.io/api/news?id=6310569c4276657a4681c0e2da205eef7ecfa5255adbe404f4e05c5f77927e37",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756362059,
      "headline": "mRNA Biotechs - Long-Term Value Risks Abound",
      "id": 136556929,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2213997299/image_2213997299.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "mRNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.",
      "url": "https://finnhub.io/api/news?id=6310569c4276657a4681c0e2da205eef7ecfa5255adbe404f4e05c5f77927e37"
    }
  }
]